$6.20
-0.01-0.16%
At close: May 15, 5:00 PM EST
$6.10
-0.10-1.61%
After Hours: May 5, 5:33 PM EST
Champions Oncology Inc Analyst Ratings
CSBRNASDAQ
Champions Oncology Analyst Ratings and Price Targets | NASDAQ:CSBR | Benzinga
Champions Oncology Inc has a consensus price target of $9.75 based on the ratings of 2 analysts. The high is $12 issued by Craig-Hallum on March 12, 2025. The low is $7.5 issued by Roth MKM on September 22, 2023. The 3 most-recent analyst ratings were released by Craig-Hallum on March 12, 2025, December 12, 2024, and September 12, 2024, respectively. With an average price target of $8.67 between Craig-Hallum, there's an implied 42.08% upside for Champions Oncology Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
Roth MKM
1calculated from analyst ratings
Analyst Ratings for Champions Oncology
Loading calendar...
FAQ
What is the target price for Champions Oncology (CSBR) stock?
The latest price target for Champions Oncology (NASDAQ:CSBR) was reported by Craig-Hallum on March 12, 2025. The analyst firm set a price target for $12.00 expecting CSBR to rise to within 12 months (a possible 96.72% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Champions Oncology (CSBR)?
The latest analyst rating for Champions Oncology (NASDAQ:CSBR) was provided by Craig-Hallum, and Champions Oncology maintained their buy rating.
When was the last upgrade for Champions Oncology (CSBR)?
The last upgrade for Champions Oncology Inc happened on September 12, 2024 when Craig-Hallum raised their price target to $6. Craig-Hallum previously had a hold for Champions Oncology Inc.
When was the last downgrade for Champions Oncology (CSBR)?
The last downgrade for Champions Oncology Inc happened on March 13, 2024 when Craig-Hallum changed their price target from N/A to N/A for Champions Oncology Inc.
When is the next analyst rating going to be posted or updated for Champions Oncology (CSBR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Champions Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Champions Oncology was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.
Is the Analyst Rating Champions Oncology (CSBR) correct?
While ratings are subjective and will change, the latest Champions Oncology (CSBR) rating was a maintained with a price target of $8.00 to $12.00. The current price Champions Oncology (CSBR) is trading at is $6.10, which is out of the analyst’s predicted range.
